Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts

Biotechnology and Bioengineering

Volumn 109, Issue 8, 2012, Pages 1898-1911

  Bryers, James D ^a   Giachelli, Cecilia M ^a   Ratner, Buddy D ^a  

^a University of Washington   (United States)

Author keywords

Foreign body response; Macrophage phenotype; Tissue regeneration

Indexed keywords

FAILURE ROUTES; FOREIGN BODY REACTIONS; FOREIGN BODY RESPONSE; IMPLANTED MEDICAL DEVICES; PARADIGM SHIFTS; TISSUE REGENERATION;

IMPLANTS (SURGICAL); TISSUE;

BIOCOMPATIBILITY;

2 HYDROXYETHYL METHACRYLATE; 4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; BIOMATERIAL; CYTOKINE; MATRIX METALLOPROTEINASE; POLYMER; RHO KINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; Y 32885;

BIOCOMPATIBILITY; BIOENGINEERING; BIOFOULING; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL INFILTRATION; CELL PHAGOCYTOSIS; CHEMOTAXIS; CYTOKINE PRODUCTION; DRUG EFFECT; ENCAPSULATION; FOREIGN BODY REACTION; GRANULATION TISSUE; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PHAGOCYTE; POROSITY; REVIEW; STEROID RELEASE; TISSUE REGENERATION; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; FOREIGN-BODY REACTION; PROSTHESES AND IMPLANTS;

EID: 84862702111     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24559     Document Type: Review

References (161)

1. Amiji M, Park H, Park K. 1992. Study on the prevention of surface-induced platelet activation by albumin coating. J Biomater Sci Polym Ed 3(5): 375- 388.
2. Anderson J. 2001. Biological responses to biomaterials. Annu Rev Mater Res 31: 81- 110.
3. Anderson J, Bonfield T, Ziats N. 1990. Protein adsorption and cellular adhesion and activation on biomedical polymers. Int J Artif Organs 13: 375- 382.
4. Anderson JM, Rodriguez A, Chang DT. 2008. Foreign body reaction to biomaterials. Semin Immunol 20(2): 86- 100.
5. Andrade J, Hlady V. 1987. Plasma protein adsorption: The big twelve. Ann NY Acad Sci 516: 158- 172.
6. Atzet S, Curtin S, Trinh P, Bryant S, Ratner B. 2008. Degradable poly(2-hydroxyethyl methacrylate)-co-polycaprolactone hydrogels for tissue engineering scaffolds. Biomacromolecules 9(12): 3370- 3377.
7. Babu M, Diegelmann R, Oliver N. 1989. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 9: 1642- 1650.
8. Badylak SF. 2007. The extracellular matrix as a biologic scaffold material. Biomaterials 28: 3587- 3593.
9. Beckstead BL, Tung JC, Liang KJ, Tavakkol Z, Usui ML, Olerud JE, Giachelli CM. 2009. Methods to promote notch signaling at the biomaterial interface and evaluation in a rafted organ culture model. J Biomed Mater ResA 91A(2): 436- 446.
10. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. 2003. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24: 2497- 2502.
11. Bergman A, Zygourakis K. 1999. Migration of lymphocytes on fibronectin-coated surfaces: Temporal evaluation of migratory parameters. Biomaterials 20: 2235- 2244.
12. Bota PCS, Collie AMB, Puolakkainen P, Vernon RB, Sage EH, Ratner BD, Stayton PS. 2010. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater ResA 95(2): 649- 657.
13. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ. 2001. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17: 945- 950.
14. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. 1995. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 29: 1517- 1524.
15. Brodbeck W, MacEwan M, Colton E, Meyerson H, Anderson J. 2005. Lymphocytes and the foreign body response: Lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res 74A: 222- 229.
16. Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE. 2003. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. Circ Res 93(4): e38- e47.
17. Cai K, Yao K, Cui Y, Lin S, Yang Z, Li X, Xie H, Qing T, Luo J. 2002. Surface modification of poly(D, L-lactic acid) with chitosan and its effects on the culture of osteoblasts in vitro. J Biomed Mater Res 60: 398- 404.
18. Chung TW, Yang J, Akaike T, Cho KY, Nah JW, Kim SI, Cho CS. 2002. Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 23: 2827- 2834.
19. Chvapil M. 1977. Collagen sponge: Theory and practice of medical applications. J Biomed Mater Res 11: 721- 741.
20. Cotran R, Kumar V, Robbins S, editors. 1999. Pathologic basis of disease, 6th edn. Philadelphia, PA: Saunders Publishing.
21. Dantzer E, Braye FM. 2001. Reconstructive surgery using an artificial dermis (integra): Results with 39 grafts. Br J Plast Surg 54: 659- 664.
22. Dar A, Shachar M, Leor J, Cohen S. 2002. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 80: 305- 312.
23. Denuziere A, Ferrier D, Damour O, Domard A. 1998. Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: Biological properties. Biomaterials 19: 1275- 1285.
24. Dziuk PJ, Cook B. 1966. Passage of steroids through silicone rubber. Endocrinology 78(1): 208- 211.
25. Edmondson S, Osborne VL, Huck WT. 2004. Polymer brushes via surface-initiated polymerizations. Chem Soc Rev 33(1): 14- 22.
26. Engelberg I, Kohn J. 1991. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study. Biomaterials 12: 292- 304.
27. Fukano Y, Knowles NG, Usui ML, Underwood RA, Hauch KD, Marshall AJ, Ratner BD, Giachelli CM, Carter WG, Fleckman P, Olerud JE. 2006. Characterization of an in vitro model for evaluating the interface between skin and percutaneous biomaterials. Wound Repair Regen 14(4): 484- 491.
28. Fukano Y, Usui ML, Underwood RA, Isenhath S, Marshall AJ, Hauch KD, Ratner BD, Olerud JE, Fleckman P. 2010. Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice. J Biomed Mater Res A 94(4): 1172- 1186.
29. Gallin J, Synderman R, editors. 1999. Inflammation: Basic principles and clinical correlates, 2nd edn. New York, NY: Raven Publishing.
30. Gao J, Niklason L, Langer R. 1998. Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells. J Biomed Mater Res 42: 417- 424.
31. Geelhood SJ, Horbett TA, Ward WK, Wood MD, Quinn MJ. 2007. Passivating protein coatings for implantable glucose sensors: Evaluation of protein retention. J Biomed Mater Res B 81(1): 251- 260.
32. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. 1998. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152(2): 353- 358.
33. Gordon S. 2003. Alternative activation of macrophages. Nat Rev Immunol 3(1): 23- 35.
34. Goreish HH, Lewis AL, Rose S, Lloyd AW. 2004. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: In vitro and in vivo observations. J Biomed Mater Res A 68(1): 1- 9.
35. Gratchev A, Kzhyshkowska J, Kothe K, Muller-Molinet I, Kannookadan S, Utikal J, Goerdt S. 2006. M phi 1 and M phi 2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 211(6-8): 473- 486.
36. Gunatillake PA, Adhikari R. 2003. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 5: 1- 16.
37. Henson P. 1971. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol 107: 1535- 1546.
38. Henson P. 1980. Mechanisms of exocytosis in phagocytic inflammatory cells. Parke-Davis award lecture. Am J Pathol 101: 494- 511.
39. Henson P, Johnston RJ. 1987. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest 79: 669- 674.
40. Hoffman AS. 2002. Hydrogels for biomedical applications. Adv Drug Deliv Rev 54(1): 3- 12.
41. Hu W, Eaton J, Tang L. 2001. Molecular basis of biomaterial-mediated foreign body reactions. Blood 98: 1231- 1238.
42. Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. 2005. In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials 26: 7616- 7627.
43. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T. 2002. The mononuclear phagocyte system revisited. J Leukoc Biol 72(4): 621- 627.
44. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. 2001. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 55: 203- 216.
45. Isenhath SN, Fukano Y, Usui ML, Underwood RA, Irvin CA, Marshall AJ, Hauch KD, Ratner BD, Fleckman P, Olerud JE. 2007. A mouse model to evaluate the interface between skin and a percutaneous device. J Biomed Mater Res A 83A(4): 915- 922.
46. Iwasaki Y, Ishihara K, Nakabayashi N, Khang G, Jeon JH, Lee JW, Lee HB. 1998. Platelet adhesion on the gradient surfaces grafted with phospholipid polymer. J Biomater Sci Polym Ed 9(8): 801- 816.
47. Jabs A, Moncada GA, Nichols CE, Waller EK, Wilcox JN. 2005. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J Vasc Res 42(2): 174- 180.
48. Jay SM, Skokos E, Laiwalla F, Krady MM, Kyriakides TR. 2007. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am J Pathol 171(2): 632- 640.
49. Jockenhoevel S, Chalabi K, Sachweh JS, Groesdonk HV, Demircan L, Grossmann M, Zund G, Messmer BJ. 2001. Tissue engineering: Complete autologous valve conduit-A new moulding technique. Thorac Cardiovasc Surg 49: 287- 290.
50. Johnston RJ. 1988. Current concepts: Immunology. Monocytes and macrophages. N Engl J Med 318: 747- 752.
51. Jono S, Peinado C, Giachelli CM. 2000. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275(26): 20197- 20203.
52. Kao W. 1999. Evaluation of protein-modulated macrophage behavior on biomaterials: Designing biomimetic materials for cellular engineering. Biomaterials 20: 2213- 2221.
53. Karp R, Johnson K, Buoen L, Ghobrial H, Brand I, Brand K. 1973. Tumorigenesis by millipore filters in mice: Histology and ultrastructure of tissue reactions as related to pore size. J Natl Cancer Inst 51(4): 1275- 1285.
54. Keselowsky BG, Bridges AW, Burns KL, Tate CC, Babensee JE, LaPlaca MC, García AJ. 2007. Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials 28(25): 3626- 3631.
55. Kessler PD, Byrne BJ. 1999. Myoblast cell grafting into heart muscle: Cellular biology and potential applications. Annu Rev Physiol 61: 219- 242.
56. Kingshott P, Griesser HJ. 1999. Surfaces that resist bioadhesion. Curr Opin Solid State Mater Sci 4(4): 403- 412.
57. Knowles NG, Miyashita Y, Usui ML, Marshall AJ, Pirrone A, Hauch KD, Ratner BD, Underwood RA, Fleckman P, Olerud JE. 2005. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. J Biomed Mater Res A 74A(3): 482- 488.
58. Kopecek J. 2007. Hydrogel biomaterials: A smart future? Biomaterials 28(34): 5185- 5192.
59. Kudo H, Sawada T, Kazawa E, Yoshida H, Iwasaki Y, Mitsubayashi K. 2006. A flexible and wearable glucose sensor based on functional polymers with soft-MEMS techniques. Biosens Bioelectron 22(4): 558- 562.
60. Kuwana M, Okazaki Y, Kodama H, Satoh T, Kawakami Y, Ikeda Y. 2006. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 24(12): 2733- 2743.
61. Kyriakides TR, Hartzel T, Huynh G, Bornstein P. 2001. Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery. Mol Ther 3(6): 842- 849.
62. Kyriakides TR, Foster MJ, Keeney GE, Tsai A, Giachelli CM, Clark-Lewis I, Rollins BJ, Bornstein P. 2004. The CC chemokine ligand, CCL2/MCP-1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol 165: 2157- 2166.
63. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. 2000. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 51: 586- 595.
64. Lavik E, Teng YD, Snyder E, Langer R. 2002. Seeding neural stem cells on scaffolds of PGA, PLA, and their copolymers. Methods Mol Biol 198: 89- 97.
65. Lehrer R, Ganz T, Selsted M, Babior B, Curnutte J. 1988. Neutrophils and host defense. Ann Intern Med 109: 127- 142.
66. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101(7): 1468- 1478.
67. Lindahl U, Kusche Gullberg M, Kjellen L. 1998. Regulated diversity of heparan sulfate. J Biol Chem 273: 24979- 24982.
68. Linnes MP, Ratner BD, Giachelli CM. 2007. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 28(35): 5298- 5306.
69. Lowry KJ, Hamson KR, Bear L, Peng YB, Calaluce R, Evans ML, Anglen JO, Allen WC. 1997. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. J Biomed Mater Res 36: 536- 541.
70. Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL, Hauch KD, Laflamme MA, Murry CE, Ratner BD. 2010. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA 107(34): 15211- 15216.
71. Madihally SV, Matthew HW. 1999. Porous chitosan scaffolds for tissue engineering. Biomaterials 20: 1133- 1142.
72. Malafaya PB, Silva GA, Reis RL. 2007. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 59: 207- 233.
73. Malech H, Gallin J. 1987. Current concepts: Immunology. Neutrophils in human diseases. N Engl J Med 317: 687- 694.
74. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12): 677- 686.
75. Mao JS, Liu HF, Yin YJ, Yao KD. 2003. The properties of chitosan-gelatin membranes and scaffolds modified with hyaluronic acid by different methods. Biomaterials 24: 1621- 1629.
76. Marra KG, Szem JW, Kumta PN, DiMilla PA, Weiss LE. 1999. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J Biomed Mater Res 47: 324- 335.
77. Marshall AJ, Irvin CA, Barker T, Sage EH, Hauch KD, Ratner BD. 2004. Biomaterials with tightly controlled pore size that promote vascular in-growth. ACS Polymer Preprints 45(2): 100- 101.
78. Martin P, Leibovich S. 2005. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 15: 599- 607.
79. Mekori Y, Metcalfe D. 2000. Mast cells in innate immunity. Immunol Rev 173: 131- 140.
80. Mendelsohn JD, Yang SY, Hiller J, Hochbaum AI, Rubner MF. 2003. Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films. Biomacromolecules 4(1): 96- 106.
81. Michel R, Pasche S, Textor M, Castner DG. 2005. Influence of PEG architecture on protein adsorption and conformation. Langmuir 21(26): 12327- 12332.
82. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, Vacanti JP. 1994. Preparation and characterization of poly(L-lactic acid) foams. Polymer 35: 1068- 1077.
83. Mizuno K, Yamamura K, Yano K, Osada T, Saeki S, Takimoto N, Sakurai T, Nimura Y. 2003. Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice. J Biomed Mater Res 64: 177- 181.
84. Mooney D, Hansen L, Vacanti J, Langer R, Farmer S, Ingber D. 1992. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix. J Cell Physiol 151: 497- 505.
85. Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R. 1996a. Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17: 1417- 1422.
86. Mooney DJ, Mazzoni CL, Breuer C, McNamara K, Hern D, Vacanti JP, Langer R. 1996b. Stabilized polyglycolic acid fibrebased tubes for tissue engineering. Biomaterials 17: 115- 124.
87. Mooney JE, Rolfe BE, Osborne GW, Sester DP, van Rooijen N, Campbell GR, Hume DA, Campbell JH. 2010. Cellular plasticity of inflammatory myeloid cells in the peritoneal foreign body response. Am J Pathol 176(1): 369- 380.
88. Mori R, Shaw TJ, Martin P. 2008. Molecular mechanisms linking wound inflammation and fibrosis: Knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 205(1): 43- 51.
89. Morra M. 2000. On the molecular basis of fouling resistance. J Biomater Sci Polym Ed 11(6): 547- 569.
90. Mosser DM. 2003. The many faces of macrophage activation. J Leukoc Biol 73(2): 209- 212.
91. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12): 958- 969.
92. Munder M, Eichmann K, Modolell M. 1998. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase arginase balance: Competitive regulation by CD4(+) T cells correlates with Th1/Th2 phenotype. J Immunol 160(11): 5347- 5354.
93. Murray PJ. 2006. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6(4): 379- 386.
94. Mytar B, Siedlar M, Woloszyn M, Ruggiero I, Pryjma J, Zembala M. 1999. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Br J Cancer 79(5-6): 737- 743.
95. Nakamura T, Hitomi S, Watanabe S, Shimizu Y, Jamshidi K, Hyon SH, Ikada Y. 1989. Bioabsorption of polylactides with different molecular properties. J Biomed Mater Res 23: 1115- 1130.
96. Nath N, Chilkoti A. 2002. Creating "smart" surfaces using stimuli responsive polymers. Adv Mater 14(17): 1243- 1247.
97. Nayak S, Lyon LA. 2004. Ligand-functionalized core/shell microgels with permselective shells. Angew Chem Int Ed Engl 43(48): 6706- 6709.
98. Nolan CM, Reyes CD, Debord JD, García AJ, Lyon LA. 2005. Phase transition behavior, protein adsorption, and cell adhesion resistance of poly(ethylene glycol) cross-linked microgel particles. Biomacromolecules 6(4): 2032- 2039.
99. Oberpenning F, Meng J, Yoo JJ, Atala A. 1999. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17: 149- 155.
100. Ohri R, Tung E, Rajachar R, Giachelli CM. 2005. Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin. Calcif Tissue Int 76(4): 307- 315.
101. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ. 1999. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2): 571- 580.
102. Orgill DP, Straus FH II, Lee RC. 1999. The use of collagen-GAG membranes in reconstructive surgery. Ann NY Acad Sci 888: 233- 248.
103. Osathanon T, Linnes MP, Rajachar RM, Ratner BD, Somerman MJ, Giachelli CM. 2008. Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials 29(30): 4091- 4099.
104. Osathanon T, Giachelli CM, Somerman MJ. 2009. Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials 30(27): 4513- 4521.
105. Ozawa T, Mickle DA, Weisel RD, Koyama N, Wong H, Ozawa S, Li RK. 2002. Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. J Thorac Cardiovasc Surg 124: 1157- 1164.
106. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RA. 2001. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59(5): 1762- 1769.
107. Park HJ, Bae YH. 2003. Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide) or poly(dimethyl siloxane). III. In vivo biocompatibility and biostability. J Biomed Mater Res A 64(2): 309- 319.
108. Pattison MA, Wurster S, Webster TJ, Haberstroh KM. 2005. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials 26: 2491- 2500.
109. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME. 2003. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 63(2): 543- 553.
110. Picha GJ, Drake RF. 1996. Pillared-surface microstructure and soft-tissue implants: Effect of implant site and fixation. J Biomed Mater Res B 30(3): 305- 312.
111. Pieper JS, Hafmans T, van Wachem PB, van Luyn MJ, Brouwer LA, Veerkamp JH, van Kuppevelt TH. 2002. Loading of collagen-heparan sulfate matrices with βFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 62: 185- 194.
112. Pober J, Cotran R. 1990a. The role of endothelial cells in inflammation. Transplantation 50: 537- 544.
113. Pober J, Cotran R. 1990b. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1: 225- 235.
114. Prichard HL, Reichert WM, Klitzman B. 2007. Adult adipose-derived stem cell attachment to biomaterials. Biomaterials 28(6): 936- 946.
115. Prime KL, Whitesides GM. 1993. Adsorption of proteins onto surfaces containing end-attached oligo(ethylene oxide): A model system using self-assembled monolayers. J Am Chem Soc 115: 10714- 10721.
116. Quinn CP, Pathak CP, Heller A, Hubbell JA. 1995. Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. Biomaterials 16(5): 389- 396.
117. Rajachar RM, Tung E, Truong AQ, Look A, Giachelli CM. 2009. Role of carbonic anhydrase II in ectopic calcification. Cardiovasc Pathol 18(2): 77- 82.
118. Ratner BD. 1996. The engineering of biomaterials exhibiting recognition and specificity. J Mol Recognit 9: 617- 625.
119. Ronneberger B, Kao WJ, Anderson JM, Kissel T. 1996. In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-co-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks. J Biomed Mater Res 30(1): 31- 40.
120. Rothenburger M, Vischer P, Volker W, Glasmacher B, Berendes E, Scheld HH, Deiwick M. 2001. In vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thorac Cardiovasc Surg 49: 204- 209.
121. Santhosh TR, Krishnan LK. 2001. Endothelial cell growth factor (ECGF) enmeshed with fibrin matrix enhances proliferation of EC in vitro. Biomaterials 22: 2769- 2776.
122. Saul JM, Linnes MP, Ratner BD, Giachelli CM, Pun SH. 2007. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression. Biomaterials 28(31): 4705- 4716.
123. Savill J. 1996. Phagocyte recognition of apoptotic cells. Biochem Soc Trans 24: 1065- 1069.
124. Schwartz B, Karsan A, Bombeli T, Harlan J. 1999. A novel beta 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J Immunol 162: 4842- 4848.
125. Sharifi BG, Zeng ZH, Wang L, Song L, Chen HM, Qin MH, Sierra-Honigmann MR, Wachsmann-Hogiu S, Shah PK. 2006. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol 26(6): 1273- 1280.
126. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. 1997. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res B 37(3): 401- 412.
127. Shen M, Martinson L, Wagner MS, Castner DG, Ratner BD, Horbett TA. 2002. PEO-like plasma polymerized tetraglyme surface interactions with leukocytes and proteins: In vitro and in vivo studies. J Biomater Sci Polym Ed 13(4): 367- 390.
128. Singh N, Bridges AW, García AJ, Lyon LA. 2007. Covalent tethering of functional microgel films onto poly(ethylene terephthalate) surfaces. Biomacromolecules 8(10): 3271- 3275.
129. Singla A, Lee CH. 2002. Effect of elastin on the calcification rate of collagene-lastin matrix systems. J Biomed Mater Res 60: 368- 374.
130. Spilker MH, Asano K, Yannas IV, Spector M. 2001. Contraction of collagen-glycosaminoglycan matrices by peripheral nerve cells in vitro. Biomaterials 22: 1085- 1093.
131. Stein M, Keshav S, Harris N, Gordon S. 1992. Interleukin-4 potently enhances murine macrophage mannose receptor activity-A marker of alternative immunological macrophage activation. J Exp Med 176(1): 287- 292.
132. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. 2002. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161(6): 2035- 2046.
133. Stokes KB. 1988. Preliminary studies on a new steroid eluting epicardial electrode. Pacing Clin Electrophysiol 11( 11 Pt 2): 1797- 1803.
134. Szleifer I. 1997a. Protein adsorption on tethered polymer layers: Effect of polymer chain architecture and composition. Physica A 244(1-4): 370- 388.
135. Szleifer I. 1997b. Polymers and proteins: Interactions at interfaces. Curr Opin Solid State Mater Sci 2(3): 337- 344.
136. Takahashi H, Wang Y, Grainger DW. 2010. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. J Control Release 147: 400- 407.
137. Tan W, Krishnaraj R, Desai TA. 2001. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng 7: 203- 210.
138. Tang L, Eaton J. 1993. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 178: 2147- 2156.
139. Tang L, Jennings T, Eaton J. 1998. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 95: 8841- 8846.
140. Taylor PM, Allen SP, Dreger SA, Yacoub MH. 2002. Human cardiac valve interstitial cells in collagen sponge: A biological three-dimensional matrix for tissue engineering. J Heart Valve Dis 11: 298- 306.
141. Tsai AT, Rice J, Scatena M, Liaw L, Ratner BD, Giachelli CM. 2005. The role of osteopontin in foreign body giant cell formation. Biomaterials 26(29): 5835- 5843.
142. Unsworth LD, Sheardown H, Brash JL. 2005. Polyethylene oxide surfaces of variable chain density by chemisorption of PEO-thiol on gold: Adsorption of proteins from plasma studied by radiolabelling and immunoblotting. Biomaterials 26(30): 5927- 5933.
143. Unsworth LD, Sheardown H, Brash JL. 2008. Protein-resistant poly(ethylene oxide)-grafted surfaces: Chain density-dependent multiple mechanisms of action. Langmuir 24(5): 1924- 1929.
144. Verreck FAW, de Boer T, Langenberg DML, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff THM. 2004. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria. PNAS 101(13): 4560- 4565.
145. von Recum AF, Shannon CE, Cannon CE, Long KJ, Kooten TG, Meyle J. 1996. Surface roughness, porosity, and texture as modifiers of cellular adhesion. Tissue Eng 2(4): 241- 253.
146. Vorotnikova E, Mcintosh D, Dewilde A, Zhang J, Reing JE, Zhang L, Cordero K, Bedelbaeva K, Gourevitch D, Heber-Katz E, Badylak SF, Braunhut SJ. 2010. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol 29(8): 690- 700.
147. Wagner VE, Bryers JD. 2004. Poly(ethylene glycol)-polyacrylate copolymers modified to control adherent monocyte-macrophage physiology: Interactions with attaching Staphylococcus epidermidis or Pseudomonas aeruginosa bacteria. J Biomed Mater Res A 69A(1): 79- 90.
148. Wagner VE, Koberstein JT, Bryers JD. 2004. Protein and bacterial fouling characteristics of peptide and antibody decorated surfaces of PEG-poly(acrylic acid) co-polymers. Biomaterials 25(12): 2247- 2263.
149. Wang YC, Ho CC. 2004. Micropatterning of proteins and mammalian cells on biomaterials. FASEB J 18(3): 525- 527.
150. Wang C, Yu B, Knudsen B, Harmon J, Moussy F, Moussy Y. 2008. Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules 9(2): 561- 567.
151. Williams G, Williams W. 1983. Granulomatous inflammation-A review. J Clin Pathol 36: 732- 733.
152. Wilson C, Clegg R, Leavesley D, Pearcy M. 2005. Mediation of biomaterial-cell interactions by adsorbed proteins: A review. Tissue Eng 11: 1- 18.
153. Xia Z, Triffitt JT. 2006. A review on macrophage responses to biomaterials. Biomed Mater 1(1): R1- R9.
154. Yang Y, Zhang SF, Kingston MA, Jones G, Wright G, Spencer SA. 2000. Glucose sensor with improved haemocompatibilty. Biosens Bioelectron 15(5-6): 221- 227.
155. Yang J, Goto M, Ise H, Cho CS, Akaike T. 2002. Galactosylated alginate as a scaffold for hepatocytes entrapment. Biomaterials 23: 471- 479.
156. Yannas IV. 1997. Models of organ regeneration processes induced by templates. Ann NY Acad Sci 831: 280- 293.
157. Yokoyama M, Nakahashi T, Nishimura T, Maeda M, Inoue S, Kataoka K, Sakurai Y. 1986. Adhesion behavior of rat lymphocytes to poly(ether)-poly(amino acid) block and graft copolymers. J Biomed Mater Res 20: 867- 878.
158. Zaleskas JM, Kinner B, Freyman TM, Yannas IV, Gibson LJ, Spector M. 2001. Growth factor regulation of smooth muscle actin expression and contraction of human articular chondrocytes and meniscal cells in a collagen-GAG matrix. Exp Cell Res 270: 21- 31.
159. Zhang Z, Zhang M, Chen S, Horbett T, Ratner B, Jiang S. 2008. Blood compatibility of surfaces with superlow protein adsorption. Biomaterials 29(32): 4285- 4291.
160. Zhao B, Brittain WJ. 2000. Polymer brushes: Surface-immobilized macromolecules. Prog Polym Sci 25: 677- 710.
161. Zhu H, Ji J, Lin R, Gao C, Feng L, Shen J. 2002. Surface engineering of poly(D, L-lactic acid) by entrapment of chitosan-based derivatives for the promotion of chondrogenesis. J Biomed Mater Res 62: 532- 539.